Scientists dive into the genomes of whales, elephants, and other animal giants looking for new weapons in the fight against ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

After hours: March 14 at 7:59:07 PM EDT Loading Chart for MRNA ...